2.16500 USD
0.055
2.48%
Last update Dec 16, 3:59 PM EST
Post-market
Day range
2.14
2.245
Previous close
2.22000
Open
2.19000
Access this stock data via API
Subscribe
ImmunityBio, Inc.
2.17
0.06
2.48%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 32.1M 26.4M 16.5M 7.6M
Cost of revenue 177K 136K 58K 0
Gross profit 31.9M 26.3M 16.5M 7.6M
Operating expense
Research & development 51.2M 55.2M 48.2M 35.2M
Selling general and admin 36.3M 42.3M 32.7M 41.7M
Other operating expenses
Operating income -55.6M -71.3M -64.4M -69.4M
Non operating interest income
Income 772K 818K 520K 769K
Expense 27.6M 28.9M 28.9M 14.9M
Other income expense 15.1M 7.0M -37.1M 47.0M
Pretax income -67.3M -92.3M -129.9M -59.2M
Tax provision -35K 269K -234K 0
Net income -67.3M -92.6M -129.7M -59.2M
Basic EPS -0.1 -0.1 -0.2 -0.1
Diluted EPS -0.1 -0.1 -0.2 -0.1
Basic average shares 946.6M 888.2M 853.2M 733.2M
Diluted average shares 946.6M 888.2M 853.2M 734.5M
EBITDA -51.1M -65.7M -102.7M -43.7M
Net income from continuing op. -67.3M -92.6M -129.7M -59.2M
Minority interests 21K 19K 20K 17K
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Post-market

Exchange is currently open for post-market.
Post market session closes in 2 hours 12 minutes

17:48
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).